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Abstract: Somatostatin-like immunoreactivity (SLI) was 
purified from frog brain and retina, and the structure of 
the brain peptide was determined. Frog brain (101 g) 
and retinal (45 g) tissues were extracted with 3% acetic 
acid, yielding 9.6 and 0.44 nmol of SLI, respectively. SLI 
was further purified by chromatography on a somato- 
statin immunoaffinity column followed by sequential ap- 
plication to reverse-phase C-18 HPLC columns. The brain 
and retinal peptides, purified roughly 100,000-fold with 
net yields of 7.5 and 2.3%, respectively, appeared iden- 
tical in the final steps of purification. The amino acid 
sequence of brain SLI, as determined by a gas-phase au- 
tomated Edman degradation technique, was as follows: 
Ma-Gly - (Cys)-Lys - Asn-Phe - Phe-Trp - Lys-Thr - Phe-Thr- 
Ser- (Cys). Our data indicate that despite structural vari- 
ations in somatostatins of other lower vertebrates, the 
amino acid sequence of frog brain and, by deduction, 
retinal SLI is identical to that of somatostatin tetra- 
decapeptide. These findings support the physiological rel- 
evance of studies directed at elucidating the neurotrans- 
mitter function of somatostatin using the well-established 
models of frog brain and retina. Key Words: Retinal pep- 
tides-Neuropeptides-Somatotropin release-inhibiting 
factor-Peptide sequence-Peptide purification. 
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Somatostatin, a tetradecapeptide initially isolated 
from ovine hypothalamus (Brazeau et al., 1973), has 
been shown by immunochemical techniques to be 
widely distributed in neural tissues (Hokfelt et al., 
1975a,b, 1977; Costa et al., 1977). Although evi- 
dence points to a role as a neurotransmitter or a 
modulator of neuronal activity, the function of so- 
matostatin in neurons has yet to be confirmed. The 
retina provides some specific advantages for study 
of brain peptides such as somatostatin. Not only is 
somatostatin-like immunoreactivity (SLI) present 
in a great variety of vertebrate retinas (Krisch and 
Leonhardt, 1979; Rorstad et al., 1979; Yamada et 
al., 1980; Brecha et al., 1981; Marshak and Yamada, 
1984), but the anatomy, physiology, and pharma- 
cology of the retina have been studied extensively 
and each of the major cell types has been charac- 
terized (Kaneko, 1979). The retina is easily isolated 
without contamination from other tissues and can 
be maintained in organ culture for prolonged pe- 
riods. The ability to stimulate discrete populations 
of cells within the retina with light or with phar- 
macologic reagents permits parallel electrophysio- 
logical and biochemical studies. To elucidate the 
physiological function of somatostatin in the retina, 
however, it is important first to determine the chem- 
ical structure of the peptide from the species being 
examined because of the possibility of structural 
heterogeneity, particularly in lower vertebrates 
(Hobart et al., 1980; Oyama et al., 1980; Magazin 
et al., 1982). 
For the most part, retinal SLI has been identified 
only immunochemically, with the single exception 
being a 28-amino-acid somatostatin from bovine 
retina, which has been purified and its amino acid 
sequence determined (Marshak et al., 1983). In this 
study, we sought to determine the structure of SLI 
from frog retina because of its usefulness as a model 
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for electrophysiological studies. Unfortunately, the 
minute amounts of SLI in frog retina made its pu- 
rification in quantities sufficient for amino acid se- 
quence determination difficult. To circumvent this 
problem, we purified SLI from frog retina and frog 
brain in parallel fashion. By elucidating the struc- 
ture of the latter peptide, we could deduce the 
structure of the former. 
MATERIALS AND METHODS 
Tissue extraction 
Frogs (Rana pipiens) kept on a cycle of 4 p.m.-6 a.m. 
light/6 a.m.-4 p.m. dark for 30 days were pithed and 
enucleated under dim red light on the day of dissection. 
Retinas were removed from the bisected eyecups, sepa- 
rated from pigmented epithelium, and frozen immediately 
in liquid nitrogen. Whole brains were removed from 
crania and frozen in a separate container. For extraction, 
frozen retinal and brain tissues (45 and 101 g, respec- 
tively) were placed separately in boiling water ( 5  ml/g of 
wet tissue weight) for 15 min and then homogenized in a 
blender for 5 min. An equal volume of 6% acetic acid was 
added to the homogenate to make a final concentration 
of 3% acetic acid (10 mug of tissue). After boiling for an 
additional 15 min, the extract was ultracentrifuged at 10°C 
for 35 min at 100,000 g. The precipitate was discarded, 
and the supernatant was adjusted to pH 5.0 by addition 
of ammonium hydroxide. 
Chromatography 
Small aliquots (2 ml each) of the crude extracts were 
applied to a Sephadex G5O superfine column (1 x 120 
cm) equilibrated with 0.1 M ammonium acetate, pH 5.0, 
and eluted fractions were assayed for SLI. The remainder 
of the extracts was purified on an affinity column made 
by linking anti-somatostatin antiserum 1001 to Affi-Gel 10 
by previously described methods (Marshak et al., 1983). 
The brain extracts were applied in batches of 100 ml each, 
and the entire retinal extract (500 ml) was applied in one 
batch. The sample flow rate through a 1.5- x 20-cm 
column containing 25 ml of beads was -200 ml/h. The 
column was washed with 3 column volumes of 0.1 M 
ammonium acetate, pH 5.0, and eluted with 60 ml of 2% 
trifluoroacetic acid (TFA). The void, wash, and TFA 
eluate fractions from each column were assayed for SLI, 
and the TFA eluate was pooled, diluted with 5 volumes 
of water, and applied at a flow rate of 4 ml/min to a re- 
verse-phase Z-Module C-18 HPLC column (10 km, 3.9 
nun, x 30 cm; Waters Associates, Milford, MA, U.S.A.) 
equilibrated in 0.1% TFA (buffer A). HPLC was per- 
formed with a Beckman Scientific (Fullerton, CA, 
U.S.A.) model 421 HPLC system equipped with model 
lOOA buffer pumps and a model 165 variable wavelength 
detector. The columns were eluted with a stepwise gra- 
dient (0- 100%) of a solution containing 50% acetonitrile 
in 0.1% TFA (buffer B). The eluted fractions containing 
SLI were pooled, diluted with 3 volumes of buffer A, and 
rechromatographed on the Z-Module C-18 column one or 
two additional times as indicated in Table 1. The eluted 
fractions containing SLI from the final Z-Module column 
were pooled, diluted with three volumes of buffer A, and 
chromatographed on a Vydac reverse-phase C-18 
column. The peaks of corresponding to the peaks of 
TABLE 1. Recovery of frog brain and retinal SLZ at 
each step of purification 
Recovery (%) 
SLI Purification 





Z-Module 1 3.23 
Z-Module 2 1.34 






2-Module 1 0.06 
























Only 3.30 of the 6.60 nmol was further purified. 
SLI were pooled separately and further analyzed. Re- 
covery at each step of purification was calculated on the 
basis of specific immunoreactivity per unit A220. 
Amino acid sequence analysis 
The amino acid sequence of the purified frog brain SLI 
was determined by automated Edman degradation with a 
gas-phase sequenator as previously described (Hawke et 
al., 1985). The phenylthiohydantoin derivatives of amino 
acids were analyzed by HPLC on an Ultrasphere ODS 
column (Beckman), using published methods (Hawke et 
al., 1982). Peaks were integrated and gradient elution was 
controlled with a Spectra PhysicsqSanta Clara, CA, 
U.S.A.) model 4000 integrator system. 
Radioimmunoassay 
SLI was detected by radioimmunoassay with antibody 
1001 using a modification of a previously described tech- 
nique (Yamada et al., 1980). Antibody 1001 was used at 
a dilution of 1:100,000, and samples were incubated for 
16 h at 4°C in 1 ml of buffer containing 0.05 M sodium 
phosphate (pH 7.0), 0.08 M NaCl, 0.01 M EDTA, 0.02% 
sodium azide, 0.25% bovine serum albumin, and 0.1% 
gelatin. Separation of antibody-bound and free 1251-Tyrl- 
somatostatin was achieved with 1 ml of assay buffer to 
which 25 mg/ml activated charcoal and 2.5 mg/ml dextran 
T-70 (Pharmacia, Piscataway, NJ, U.S .A. )  had been 
added. For the purpose of this study, synthetic somato- 
statin tetradecapeptide (S14; Peninsula Labs, Belmont, 
CA, U.S.A.) was used as the standard for radioimmu- 
noassays. Antibody 1001 is specific for the ring structure 
of S14 and cross-reacts 75% with somatostatin octa- 
cosapeptide (S28). Cross-reactivity with peptides altered 
at the cysteine residues in the 3 and 14 positions was 6% 
with D-cys3-s14 and 10% with D-cySI4-s14. 
RESULTS 
As indicated in Table 1 ,  9.6 nmol of SLI was ex- 
tracted from roughly 100 g of brain tissue. The yield 
of SLI from retinal tissues was -10-fold less than 
that from the brain (0.44 nmol from 45 8). Overall 
recovery of SLI following purification from brain 
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FIG. 1. Purification of frog brain SLI by HPLC. After extraction with 3% acetic acid and purification by affinity chromatography, 
frog brain SLI was subjected to HPLC on reverse-phase C-18 Z-Module (A-C) and Vydac (D) columns. The columns were 
equilibrated in 0.1% TFA and then eluted with a stepwise gradient of 50% acetonitrile in 0.1% TFA (buffer B) as indicated in 
each panel. A,,, was monitored, and the SLI in each fraction was quantified by radioimmunoassay. The fractions pooled for 
further purification (A-C) or amino acid sequencing (D) are indicated by the black bars. The elution position of synthetic S14 
is indicated in D. 
(7.5%) was better than recovery from retina (2.3%) 
despite an extra HPLC step. At each step of puri- 
fication, portions of the SLI peaks were discarded 
to enhance the purity of the pooled fractions; thus, 
the actual recovery of SLI was somewhat higher 
than the values listed in Table 1. The final purifi- 
cation factor was 110,000 for the brain extract and 
93,000 for the retinal extract. 
For both the brain and the retinal extracts, most 
of the SLI was contained in one molecular form, 
because no substantial peak other than the major 
one could be clearly segregated during the sequen- 
tial purification procedures (Figs. 1 and 2). Analysis 
of small aliquots of crude brain and retinal extracts 
by chromatography on Sephadex G50 revealed that 
most of the SLI coeluted with S14 (Fig. 3). 
At each step of purification, the major SLI peak 
was associated with multiple peaks of absorbance 
until the last HPLC step, when a single sharp A,,, 
peak corresponding to the SLI peak was clearly 
segregated (Figs. 1 and 2). The final peak of SLI 
purified from both brain and retinal extracts co- 
eluted with S14 in the isocratic portion of the elu- 
tion profile at 60% buffer B. 
Approximately 100 pmol of purified frog brain 
SLI was applied to microsequence analysis, but 
only 68 pmol of the amino terminal derivative was 
recovered in the first Edman degradation cycle. 
Nevertheless, a full sequence was obtained (Table 
2) and was found to be identical to that of S 14. The 
absence of derivatives in cycles 3 and 14 is consis- 
tent with the presence of half-cystines, which are 
not detected unless the native disulfide is chemi- 
cally modified. Furthermore, the high cross-reac- 
tivity of the purified peptide with the radioimmu- 
noassay antiserum indicates that the amino acids 
occupying positions 3 and 14 are likely to be iden- 
tical to those in S14. Although the quantities of SLI 
purified from retina were insufficient for sequence 
analysis, the exact coelution of the purified brain 
and retinal peptides on the final HPLC column in- 
dicates that in all likelihood they have an identical 
amino acid sequence. 
DISCUSSION 
Although the structure of somatostatin appears 
to be well conserved in mammals (Reichlin, 1983), 
considerable variability exists in the peptide's 
amino acid sequence in submammalian species 
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FIG. 2. Purification of frog retinal SLI by sequential HPLC on reverse-phase C-18 2-Module columns (A and B) and a C-18 
Vydac column (C). The columns were equilibrated and calibrated as in Fig. 1. 
(Table 3). Characterization of a 22-amino-acid so- 
matostatin purified from catfish pancreas indicated 
that these variations could be present even within 
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FIG. 3. Gel filtration of frog brain and retinal SLI. Brain (A) 
and retinal (8)  extracts (3% acetic acid) were applied to a 
Sephadex G50 superfine column (1 x 120 cm) and eluted 
with 0.1 M ammonium acetate, pH 5.0. Eluted fractions (2.4 
ml each) were measured for SLI by radioimmunoassay. The 
columns were calibrated by elution of bovine serum albumin 
(!lo), NaCl (VJ, S14, and S28. 
TABLE 2. Amino acid sequence of purified frog brain 
SLI by automated Edman degradation 











































Cysteine is placed in parentheses because its presence was 
deduced and not actually confirmed (see text). ND, undetect- 
able. 
Threonine was assigned on the basis of its dehydro deriva- 
tive detected at 313 nm. 
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TABLE 3.  Amino acid sequences of S14 and somatostatin of lower vertebrate species 
Relative to S 14 amino terminus 
Somatostatin -8  -7 - 6  - 5  -4 -3  -2 - 1  1 2 3 
514 Ala Gly Cys 
Frog brain Ala Gly (Cys)” 
Anglerfish I Ala Gly Cys 
Anglerfish I1 Ala Gly Cys 
Catfish pancreas Asp Asn Thr Val Thr Ser Lys Pro Leub Amb Cys 
Relative to S 14 amino terminus 
Somatostatin 4 5 6 7 8 9 10 11 12 13 14 
___ 
S14 Lys Asn Phe Phe Trp Lys Thr Phe Thr Ser Cys 
Frog brain Lys Asn Phe Phe Trp Lys Thr Phe Thr Ser (Cys)“ 
Anglerfish I Lys Asn Phe Phe Trp Lys Thr Phe Thr Ser Cys 
Anglerfish11 Lys Asn Phe TyP Trp Lys Gly” Phe Thr Ser Cys 
Catfish pancreas Metb Asn TyP Phe Trp Lys SeI-h Argb Thr Ala” Cys 
Amino acids are numbered from the amino terminus of S14. 
a Parentheses denote that the cysteine residues in position 3 and 14 of frog brain somatostatin have 
” Amino acids that vary from those in the sequence of S14. yet to be confirmed. 
1980). Subsequent use of recombinant DNA tech- 
niques has permitted the elucidation of somato- 
statin structures from a variety of species. Through 
such techniques, the amino acid sequence of catfish 
pancreatic somatostatin was confirmed, although 
corrections were required (Magazin et al., 1982), 
and two different somatostatins were identified in 
anglerfish islets (Hobart et al., 1980). The structure 
of anglerfish somatostatin I is identical to that of 
mammalian S14, but that of anglerfish somatostatin 
I1 differs by a Tyr-Phe substitution in position 7 and 
a Gly-Thr substitution in position 10. These differ- 
ences in the structure of somatostatin may have 
profound importance in the interpretation of phys- 
iological studies with synthetic S14, particularly be- 
cause lower vertebrates are useful for study of the 
neural function of somatostatin. 
Because the frog retina provides one well-devel- 
oped model for neurotransmitter studies, we un- 
dertook the simultaneous purification of SLI from 
frog brain and retina. Recent advances in biochem- 
ical techniques for purification and structural anal- 
ysis of minute quantities of peptides have permitted 
us to purify a peptide roughly 100,000-fold and to 
determine its structure even when starting with < 10 
nmol of material. Our studies indicate that frog 
brain SLI and, by deduction, retinal SLI are iden- 
tical to S14. These data confirm our previous find- 
ings in somatostatin biosynthesis studies using frog 
retinas (Yamada and Basinger, 1982). Although we 
were unable to determine the amino acid sequence 
of retinal SLI directly, our approach using simul- 
taneous purification studies has permitted us to sur- 
mise with relative confidence that the sequence is 
identical to that of brain somatostatin from the same 
species. Inasmuch as frog retinal SLI, localized and 
synthesized in situ, appears to be identical to S14, 
studies to determine the physiology of somatostatin 
in frog retina will assume functional relevance. We 
believe that our techniques may be applied to the 
purification of other neuropeptides in the retina, 
thus extending the usefulness of the retinal model 
for study of peptides as neurotransmitters. 
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